IP Library Granted Patent US 8,444,968
Granted Patent B2
US 8,444,968 · App. 11/635,265 · Granted May 21, 2013

Cartilage repair methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,444,968
App. No.
11/635,265
Granted
May 21, 2013
Kind
B2
Abstract

The present application discloses methods for repairing hyaline cartilage defects. The methods comprise a combination of introducing autologous bone mesenchymal stem cells to a joint, and applying to the joint a membrane comprising a polyester entangled with a polysaccharide. In some aspects, the bone mesenchymal stem cells are mesenchymal stem cells originating in bone underlying the joint. In these aspects, contact between the joint and the mesenchymal stem cells can be effected by introducing apertures through the bone using standard surgical techniques such as microfracture, abrasion, or drilling. Cartilage which forms in response to application of these methods is hyaline cartilage rather than fibrocartilage.

Claims (15)

1. A method for repairing a full-thickness chondral defect of a joint of a patient in need of treatment, the method comprising:

a) microfracturing bone underlying the joint;

b) applying to the joint a membrane, wherein the membrane comprises a polyester polymer entangled with a hyaluronate polymer, at a weight ratio of polyester polymer to hyaluronate polymer of between 9:1 and 1:9, wherein the entanglement of the polymers is produced by forming an emulsified mixture of the polyester polymer in a first solvent and the hyaluronate polymer in a second solvent, adding the emulsified mixture to a mold, freezing the emulsified mixture in the mold, removing solvent from the resultant frozen mixture by vacuum, wherein the membrane has a thickness of at least 0.5 mm up to 3 mm; and

c) anchoring the membrane to the joint.

2. The method in accordance with claim 1 , for repairing a full-thickness chondral defect in a knee joint, an elbow joint, or a shoulder joint, wherein said microfracturing, applying and anchoring steps are carried out on the defective joint.

3. The method in accordance with claim 1 , wherein the polyester polymers comprise a co-polymer comprising polylactic acid and polyglycolic acid.

4. The method in accordance with claim 2 , wherein the polylactic acid and the polyglycolic acid are in a weight ratio of about 5:1 to about 2:1.

5. The method in accordance with claim 1 , wherein the anchoring the membrane to the joint comprises applying at least one fastener which secures the membrane to the joint, wherein the at least one fastener is selected from the group consisting of a biocompatible glue, a suture, a tissue weld, a dart, a staple, a screw, and a tack.

6. A method for repairing a full-thickness chondral defect of a joint of a patient in need of treatment, the method comprising:

a) introducing at least one aperture through bone underlying the joint, wherein the at least one aperture makes possible migration to the joint of mesenchymal stem cells comprised by a marrow cavity of the bone;

b) applying to the joint a membrane, wherein the membrane comprises a polyester polymer entangled with a hyaluronate polymer, at a weight ratio of polyester polymer to hyaluronate polymer of between 9:1 and 1:9, wherein the entanglement of the polymers is produced by forming an emulsified mixture of the polyester polymer in a first solvent and the hyaluronate polymer in a second solvent, adding the emulsified mixture to a mold, freezing the emulsified mixture in the mold, removing solvent from the resultant frozen mixture by vacuum, wherein the membrane has a thickness of at least 0.5 mm up to 3 mm; and

c) securing the membrane to the joint.

7. The method in accordance with claim 6 , wherein the polyester polymers comprise a co-polymer comprising polylactic acid and polyglycolic acid.

8. The method in accordance with claim 7 , wherein the polylactic acid and the polyglycolic acid are in a weight ratio of about 5:1 to about 2:1.

9. The method for repairing a hyaline cartilage defect in accordance with claim 6 , wherein the securing the membrane to the joint comprises applying at least one fastener to the membrane and the joint, wherein the at least one fastener is selected from the group consisting of a biocompatible glue, a suture, a tissue weld, a dart, a staple, a screw, and a tack.

Assignments (8)
SECURITY INTEREST Recorded Sep 18, 2025
From: ISTO TECHNOLOGIES II, LLC; ADVANCED BIOLOGICS LLC,; ARTERIOCYTE MEDICAL SYSTEMS, INC.; THERACELL, LLC
To: GOLUB CAPITAL MARKETS LLC
Reel/Frame 072300/0216 →
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2025
From: BARINGS FINANCE LLC, AS COLLATERAL AGENT
To: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
Reel/Frame 072274/0408 →
RELEASE OF SECURITY INTEREST Recorded Oct 18, 2023
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: ISTO TECHNOLOGIES II, LLC
Reel/Frame 065269/0604 →
SECURITY INTEREST Recorded Oct 18, 2023
From: ARTERIOCYTE MEDICAL SYSTEMS, INC.; ISTO TECHNOLOGIES II, LLC; THERACELL, LLC; ADVANCED BIOLOGICS, LLC; BIOLOGICA TECHNOLOGIES, LLC
To: BARINGS FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065271/0059 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2018
From: ISTO TECHNOLOGIES, INC.
To: ISTO TECHNOLOGIES II, LLC
Reel/Frame 045478/0013 →
SECURITY INTEREST Recorded Jun 15, 2017
From: ISTO TECHNOLOGIES II, LLC
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 042727/0459 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2016
From: MIDCAP FUNDING XVIII TRUST, AS SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL SBIC, LP
To: ISTO TECHNOLOGIES, INC.
Reel/Frame 038903/0645 →
SECURITY INTEREST Recorded Jan 23, 2015
From: ISTO TECHNOLOGIES, INC.
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 034805/0001 →